Related Experiment Videos
Gene polymorphism association studies in dialysis: cardiovascular disease
Madhumathi Rao1, Bertrand L Jaber, Vaidyanathapuram S Balakrishnan
1Division of Nephrology, Department of Medicine, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA.
Seminars in Dialysis
|June 7, 2005
Summary
Cardiovascular disease (CVD) is a major cause of death in dialysis patients due to chronic kidney disease (CKD) risk factors. Genetic factors and their interactions influence individual risks for these complex diseases.
Area of Science:
- Nephrology
- Cardiology
- Genetics
Background:
- Cardiovascular disease (CVD) is the leading cause of death in dialysis patients.
- The high prevalence of CVD in this population is linked to cumulative risk factors from early chronic kidney disease (CKD).
- Genetic factors likely explain individual differences in susceptibility to CVD and CKD.
Purpose of the Study:
- To review cardiovascular disease in dialysis patients as a complex disease model.
- To discuss gene polymorphism association studies, including gene-environment and gene-gene interactions.
- To provide an overview of current research on genetic associations with CVD in dialysis patients.
Main Methods:
- Review of existing literature on CVD, CKD, and genetic associations.
- Examination of gene polymorphism association study methodologies.
- Analysis of gene-environment and gene-gene interaction models.
Main Results:
- CVD is a significant challenge in dialysis patients, influenced by multiple interacting risk factors.
- Genetic variations, particularly single nucleotide polymorphisms (SNPs), are being investigated for their role in disease risk.
- Gene-environment and gene-gene interactions are crucial for understanding disease complexity.
Conclusions:
- Dialysis patients represent a valuable model for studying complex cardiovascular diseases.
- Further research into genetic factors and their interactions is essential for personalized risk assessment and treatment.
- Genomic technologies offer promising avenues for understanding CVD in CKD.